Butyrate has anti-obesity effects through upstream regulation of the expression of angiopoietin-like protein-4 (ANGPTL4) in human epithelial cells, resulting in the reduced expression of lipoprotein lipase (LPL) and increased lipolysis [145]. This evidence concerns the gene LPL and obesity disorder.